Literature DB >> 14738604

Mode of parotid involvement in external auditory canal carcinoma.

Jae Young Choi1, Eun-Chang Choi, Ho-Ki Lee, Jong-Bum Yoo, Sun Goo Kim, Won-Sang Lee.   

Abstract

Until now, little was known about the mode of parotid involvement in external auditory canal (EAC) carcinoma. The incidence of parotid node metastasis and direct parotid invasion was examined in patients with EAC carcinoma. The study comprised 11 patients with squamous cell carcinomas (SCC) and 10 patients with adenoid cystic carcinomas (ACC). A retrospective review of the surgical specimens was undertaken with specific reference to parotid node metastasis and parotid invasion. Parotid node metastasis was noted only in two cases of advanced staged SCC, whereas none of the ACC patients showed parotid node metastasis. Direct parotid invasion occurred only in advanced staged SCC, however, it did occur in early stage ACC. Our data indicated that elective parotidectomy for control of occult parotid node metastasis is necessary only in advanced SCC carcinoma, whereas parotid management to secure adequate safety margins is mandatory for advanced SCC and all cases of ACC.

Entities:  

Mesh:

Year:  2003        PMID: 14738604     DOI: 10.1258/002221503322683821

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  11 in total

1.  Ceruminous gland carcinomas: a clinicopathologic and immunophenotypic study of 17 cases.

Authors:  Nikhil Crain; Brenda L Nelson; E Leon Barnes; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2008-12-03

2.  Bilateral external auditory canal squamous cell carcinoma: a case report.

Authors:  Cağdaş Elsürer; Hilmi Alper Senkal; Ehab Zayyan; Taner Yilmaz; Sefa Kaya
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-15       Impact factor: 2.503

3.  Squamous cell carcinoma of the external auditory canal.

Authors:  David Lobo; José L Llorente; Carlos Suárez
Journal:  Skull Base       Date:  2008-05

4.  Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outcomes.

Authors:  A Mazzoni; G Danesi; E Zanoletti
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

5.  Surgical treatment for squamous cell carcinoma of the temporal bone: predictors of survival.

Authors:  Conrad F Smit; Niels de Boer; Birgit I Lissenberg-Witte; Paul Merkus; Erik F Hensen; C René Leemans
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-08       Impact factor: 2.124

6.  Imaging of carcinoma of the external auditory canal: a pictorial essay.

Authors:  Cheng K Ong; Uei Pua; Vincent F H Chong
Journal:  Cancer Imaging       Date:  2008-10-20       Impact factor: 3.909

7.  Evidence Based Tailored Parotidectomy in Treating External Auditory Canal Carcinoma.

Authors:  Jeon Mi Lee; Jin Woo Joo; Sung Huhn Kim; Jae Young Choi; In Seok Moon
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

8.  Prognostic Factors Affecting Surgical Outcomes in Squamous Cell Carcinoma of External Auditory Canal.

Authors:  Gi-Sung Nam; In Seok Moon; Ji Hyung Kim; Sung Huhn Kim; Jae Young Choi; Eun Jin Son
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-05-22       Impact factor: 3.372

9.  Clinical experience of 23 cases of adenoid cystic carcinoma of the external auditory canal.

Authors:  Xiaojun Jiang; Lifeng Jia; Xueyuan Zhang; Cheng Zhong; Feng Tang; Xiaoling Chen; Wei Yuan
Journal:  Oncol Lett       Date:  2020-08-21       Impact factor: 2.967

10.  Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.

Authors:  Cindy H Nabuurs; Wietske Kievit; Nilou Labbé; C René Leemans; Conrad F G M Smit; Michiel W M van den Brekel; Robert J Pauw; Bernard F A M van der Laan; Jeroen C Jansen; Martin Lacko; Weibel W Braunius; Shinya Morita; Małgorzata Wierzbicka; Takuma Matoba; Nobuhiro Hanai; Robert P Takes; Henricus P M Kunst
Journal:  Head Neck       Date:  2020-08-13       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.